DUBLIN--(BUSINESS WIRE)--The "Global Biomarkers Market - Forecasts from 2017 to 2022" report has been added to Research and Markets' offering.
The global biomarkers market was valued at US$22.155 billion in 2017 and is expected to grow at a CAGR of 14.60% to reach a market size of US$43.793 billion by the year 2022
An indicator which measures some biological state or condition is called biomarker or biological marker. It is used for a substance which indicates presence of a living being.
There are four types of biomarkers namely predisposition biomarkers which inform about the possibility of developing a health disorder. Other biomarker is diagnostic biomarker which is utilized to affirm that a patient has a specific health disorder earlier than any other physical examination of a patient. Prognostic biomarker helps to indicate the process of development of a disease in individual when a specific disorder is diagnosed in the patient's body. The fourth type of biomarker is predictive biomarker which helps to identify patients which will get maximum benefits from following a specific treatment option.
- Safety Biomarkers
- Validation Biomarkers
- Efficacy Biomarkers
- Drug Discovery and Development
- Disease Risk Assessment
- Personalized Medicine
Key industry players profiled as part of this section are Cisbio, MESO SCALE DIAGNOSTICS, LLC, PerkinElmer Inc., Bio-Rad Laboratories, QIAGEN, BioSIMS Technologies SaS, and Signosis Inc.
Key Topics Covered:
2. Research Methodology
3. Executive Summary
4. Market Dynamics
5. Global Biomarkers Market Forecast by Type (US$ billion)
6. Global Biomarkers Market Forecast by Application (US$ billion)
7. Global Biomarkers Market Forecast by Geography (US$ billion)
8. Competitive Intelligence
9. Company Profiles
- MESO SCALE DIAGNOSTICS, LLC
- PerkinElmer Inc.
- Bio-Rad Laboratories
- BioSIMS Technologies SaS
- Signosis Inc.
For more information about this report visit https://www.researchandmarkets.com/research/glp9pb/global_biomarkers